Skip to main content

Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to September 2026.

37,142
Total recall recordsAll FDA and USDA recalls in Public Health Trace
9,799
Class I recallsReasonable probability of serious health consequences
24,349
Class II recallsTemporary or medically reversible health consequences
2,891
Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls
Most common hazardLack of assurance of sterility 2,072 recalls
Most affected stateHawaii 200 recalls mention this state

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters
Recall details
Location
Date range
Sort results
Clear filters
Metric
View
Recalls announced by month (Year to date)

A chart of recalls grouped by month.

Download CSV

Source: FDA and USDA public dataLast updated

Summary (Year to date)

  • 1,527 recalls have been announced year to date.
  • Aug 2026 was 24% lower than the previous complete period (Jul 2026: 240).
  • The highest complete period was Jun 2026 (297).
  • Sep 2026 is incomplete and not included in the figures above.
  • Complete data
  • Incomplete
Recalls by class

A bar chart of the total number of recalls in this dataset by recall class.

Recalls by class
ClassRecalls
Class II24,349
Class I9,799
Class III2,891
Not Yet Classified1
Download CSV
Recalls by class
ClassRecalls
Class II24,349
Class I9,799
Class III2,891
Not Yet Classified1

Showing 13,201–13,220 of 17,335 recalls

FDA Recall Terminated Historical recordClass I

Avastin (Bevacizumab) 1.25 mg/0.05 mL syringe, Office Administration Only, AmEx Pharmacy, 1515 Elizabeth St Suite J, Melbourne, FL 32901.

by Pacifico National, Inc. dba AmEx Pharmacy

Reason
Non-Sterility: Product tested positive for bacterial contamination.
Published
June 1, 2016
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass I

Avastin (Bevacizumab) 2 mg/0.08 mL syringe, Office Administration Only, AmEx Pharmacy, 1515 Elizabeth St Suite J, Melbourne, FL 32901.

by Pacifico National, Inc. dba AmEx Pharmacy

Reason
Non-Sterility: Product tested positive for bacterial contamination.
Published
June 1, 2016
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Linezolid Injection, 600 mg/300 mL Single use container bags (NDC 0703-9060-31), packaged in 10 x 300 mL Single Use Container bags per Box Pack (NDC 0703-9060-33), Rx only, Manufactured In Hungary By: Teva Pharmaceutical Works Ltd., Hungary, H-2100 Godollo, Tancsics M. ut 82 Hungary; Manufactured For: Teva Pharmaceuticals USA, Inc., North Wales, PA 19454

by Teva North America

Reason
Lack of Assurance of Sterility: Due to potential for leaking bags.
Published
June 1, 2016
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

OCTREOTIDE ACETATE INJECTION, 50 mcg (base)/mL (0.05 mg/mL), 1 mL Single Dose Vial, Rx only, Manufactured by Fresenius Kabi USA, LLC, Schaumburg, IL 60173, NDC 63323-365-04

by Fresenius Kabi USA, LLC

Reason
Failed Impuities/Degradation Specifications
Published
June 1, 2016
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

OCTREOTIDE ACETATE INJECTION, 50 mcg (base)/mL (0.05 mg/mL), 1 mL Single Dose Vial, Rx only, Manufactured by Fresenius Kabi USA, LLC, Schaumburg, IL 60173, NDC 63323-365-01.

by Fresenius Kabi USA, LLC

Reason
Failed Impuities/Degradation Specifications
Published
June 1, 2016
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass I

8.4% Sodium Bicarbonate Injection, USP 50mEq (1mEq/mL), 4.2 grams (84 mg/mL), 50 mL, Rx only, Hospira Inc, Lake Forest, IL 60045, NDC 0409-6625-02

by Hospira Inc.

Reason
Presence of Particulate Matter: particulate matter identified as an insect in one vial.
Published
June 1, 2016
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass I

CLINIMIX E 5/15 sulfite-free (5% Amino Acid with Electrolytes in 15% Dextrose with Calcium) Injection, 1000 mL Injection Port Chamber 30% Dextrose Injection with Calcium, 1000 mL Outlet Port Chamber 10% Amino Acid Injection with Electrolytes, 2000 mL CLARITY Dual Chamber Container bag, Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015, Product Code 2B7721, NDC 0338-1123-04.

by Baxter Healthcare Corp.

Reason
Presence of Particulate Matter: identified as dried skin.
Published
June 1, 2016
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass I

Metronidazole Injection USP, 500 mg per 100 mL (5 mg/mL), 100mL Sterile Single Dose Container bag, Rx only, Baxter USA, Product Code 2B3421, NDC 0338-1055-48.

by Baxter Healthcare Corp.

Reason
Presence of Particulate Matter: identified as a cloth fiber.
Published
June 1, 2016
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass I

0.9% Sodium Chloride Injection USP, MINI-BAG Plus Container, 100 mL VIAFLEX Single Dose Container bags, Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015, Product Code 2B0043, NDC 0338-0553-18.

by Baxter Healthcare Corp.

Reason
Presence of Particulate Matter: identified as cardboard.
Published
June 1, 2016
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

0.9% Sodium Chloride Injection USP, MINI-BAG Plus Container, 100 mL VIAFLEX Single Dose Container bags, Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015, Product Code 2B0043, NDC 0338-0553-18.

by Baxter Healthcare Corp.

Reason
Lack of Assurance of Sterility: potential for leaking containers which lacks the assurance of sterility.
Published
June 1, 2016
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass I

LIPO ESCULTURA capsules, 250 mg, 60-count bottles, Distributed By: JAT Productos Naturales Corp., BROOKLYN, NY 11238, www.lipoesculturatreatment.com

by Lipo Escultura Corp.

Reason
Marketed Without An Approved NDA/ANDA: Tainted product marketed as a dietary supplement. Product found to be tainted with sibutramine, an appetite suppressant that was withdrawn from the U.S. market in October 2010 for safety reasons, and diclofenac, a prescription non-steroidal anti-inflammatory drug, making this an unapproved drug.
Published
June 1, 2016
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass I

Amikacin Sulfate injection USP,1 gm/4 mL (250 mg/mL) 4mL vial, Rx only, Manufactured in Hungary For: Teva Pharmaceuticals USA, INC. North Wales, PA 19454. Individual Pack NDC 0703-9040-01, Shelf Pack NDC 0703-9040-03

by Teva Pharmaceuticals USA

Reason
Presence of Particulate Matter: particulate matter identified as glass in one vial.
Published
June 1, 2016
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Sclerosol Intrapleural Aerosol (sterile talc powder), Intrapleural administration, 4 g Canister, Rx Only, Distributed by: Bryan Corporation, Woburn, MA 01801, USA, NDC 63256-100-30

by Lymol Medical

Reason
Defective Delivery System: Defective stem valve causes leakage of the propellant in the spray canister delivering no drug or an inadequate amount of the drug to be delivered.
Published
June 1, 2016
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Zoloft (sertraline HCl) tablets, 100 mg*, 30 count bottles, Rx only, Distributed by Roerig, Division of Pfizer, Inc., NY NY 10017, NDC 0049-4910-30.

by Pfizer Inc.

Reason
Failed Tablet/Capsule Specifications: thick tablets exceeding specifications were found.
Published
June 1, 2016
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

col-rite (docusate sodium) stool softener softgels, 50 mg, packaged in a) 30-count, item 351104, UPC 0 11822 51104 9; and b) 60-count, item 357392, UPC 0 11822 57392 4; DISTRIBUTED BY: RITE AID, 30 HUNTER LANE, CAMP HILL , PA 17011.

by Allegiant Health

Reason
Superpotent Drug: High out of specification results for assay at the 6 month time point interval.
Published
May 25, 2016
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Renovo Patch (Capsaicin, 0.0375%, Menthol, USP 5.00%), 3-count patches per carton, Rx only, Distributed By: TMIG Inc, Marietta , GA 30062, Manufactured By: Pocono Coated Products LLC., Cherryville, NC 28021 NDC: 69176-025-03

by TMIG Inc

Reason
Marketed Without An Approved NDA/ANDA: product is an unapproved drug and additionally 3 lots were found to be subpotent.
Published
May 25, 2016
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass III

Magnesium Sulfate Inj., USP 50%, 10 g/20 mL (0.5 g/mL), (4 mEq Magnesium/mL, 20 mL Single-dose vial, packaged in 25 vials per box, Rx Only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-2168-02, barcode (01) 2 030409 216802 5.

by Hospira Inc.

Reason
Failed pH Specifications: Confirmed high out of specification (OOS) results for pH.
Published
May 25, 2016
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Brevibloc DOUBLE STRENGTH Premixed Injection, Esmolol Hydrochloride in Sodium Chloride, 2000mg/100mL (20 mg/mL), 100 mL, Rx only, Manufactured by Baxter Healthcare Corporation, Deerfield, Il 60015, NDC 10019-075-87

by Baxter Healthcare Corp.

Reason
Discoloration: presence of atypical yellow discoloration of the solution .
Published
May 18, 2016
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Ondansetron Tablets USP, 4 mg, 30 count bottles, Rx only, Manufactured by: Dr. Reddy's Laboratories, Bachupally, India --- NDC 56111-153-30

by Dr. Reddy's Laboratories, Inc.

Reason
Failed Impurities/Degradation Specifications; 12 month stability time point
Published
May 18, 2016
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Paliperidone Extended-release Tablets, 1.5 mg, 30 count bottles, Rx only, Mylan Pharmaceuticals, Inc., Morgantown, WV --- NDC 0378-3978-93

by Mylan Pharmaceuticals Inc.

Reason
Failed Dissolution Specifications; three month stability time point.
Published
May 18, 2016
Distribution
Nationwide

View recall →

Data last updated:

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.